Dae Hyun Ha

Title: Dae Hyun Ha: Innovator in Cancer Treatment

Introduction

Dae Hyun Ha is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. With a total of 2 patents, his work focuses on developing compositions and peptides that target cancer cells effectively.

Latest Patents

Dae Hyun Ha's latest patents include a composition comprising a compound that inhibits interactions of MBD2 and p66α for anti-metastasis and the prevention and treatment of cancer disease. This invention relates to a composition that includes an inhibitor against the function of an Mi-2/NuRD chromatin remodeling complex, which is crucial for inhibiting metastasis and treating cancer diseases. The composition is expected to be effectively used in clinical applications aimed at preventing and treating cancer.

Another notable patent is a peptide that exhibits anticancer activity, along with a pharmaceutical composition and dietary supplement composition for preventing and treating cancer. This peptide binds to the transcription factor CP2c and has shown the ability to inhibit the DNA binding capability of CP2c, thereby disrupting cancer cell-specific transcriptional activity. This innovative approach allows for targeted treatment of cancer cells, making it a valuable addition to cancer prevention strategies.

Career Highlights

Dae Hyun Ha has worked with various institutions, contributing to advancements in cancer research. His career includes significant roles at the Industry-University Cooperation Foundation of Hanyang University and the University of South Florida. His work in these institutions has facilitated the translation of research into practical applications in the medical field.

Collaborations

Dae Hyun Ha has collaborated with notable colleagues, including Chul Geun Kim and Min Young Kim. These partnerships have enhanced the scope and impact of his research, leading to innovative solutions in cancer treatment.

Conclusion

Dae Hyun Ha's contributions to cancer research through his patents and collaborations highlight his commitment to advancing medical science. His innovative approaches in developing targeted therapies for cancer treatment are paving the way for future breakthroughs in the field.